Free Trial

ConvaTec Group (CTEC) Share Price, News & Analysis

GBX 247.40
-3.60 (-1.43%)
(As of 07/24/2024 ET)
Today's Range
50-Day Range
52-Week Range
1.87 million shs
Average Volume
5.39 million shs
Market Capitalization
£5.07 billion
P/E Ratio
Dividend Yield
Price Target
GBX 307.17
CTEC stock logo

About ConvaTec Group Stock (LON:CTEC)

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other causes, as well as critical care devices and products used in intensive care units and hospital settings. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for pumps used in continuous subcutaneous infusion treatments for conditions such as parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.

CTEC Stock Price History

CTEC Stock News Headlines

Convatec Group PLC: Director/ PDMR Shareholding -2-
Convatec Group PLC: Director/ PDMR Shareholding
Fed's New Power to Seize Bank Accounts
For months I’ve been warning about the federal government’s terrifying new program to control every American’s bank account.
ConvaTec Group PLC FY EPS 6.3c
ConvaTec Group PLC (CTEC)
Fed's New Power to Seize Bank Accounts
For months I’ve been warning about the federal government’s terrifying new program to control every American’s bank account.
Convatec Group Plc (CTEC.L)
Convatec Group PLC: TR-1 Notification of Major Holdings
Convatec Group PLC: HOL-Holding(s) in Company
See More Headlines
Receive CTEC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ConvaTec Group and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Ex-Dividend for 5/23 Dividend
Dividend Payable

Industry, Sector and Symbol

Medical Instruments & Supplies
Year Founded

Price Target and Rating

Average Stock Price Target
GBX 307.17
High Stock Price Target
GBX 323
Low Stock Price Target
GBX 300
Potential Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
6 Analysts


Net Income
£130.30 million
Pretax Margin


Sales & Book Value

Annual Sales
£2.14 billion
Cash Flow
GBX 14.55 per share
Book Value
GBX 83 per share


Outstanding Shares
Free Float
Market Cap
£5.07 billion
Not Optionable
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Mr. Karim Bitar (Age 59)
    CEO & Director
    Comp: $2.97M
  • Mr. Jonathan Peter Mason (Age 60)
    Group CFO & Director
    Comp: $1.59M
  • Mr. John Haller
    Executive VP and Chief Quality & Operations Officer
  • Dr. Divakar Ramakrishnan Ph.D.
    Executive VP, Chief Technology Officer and Head of Research & Development
  • Ms. Kate Postans
    Vice President of Investor Relations & Corporate Communications
  • Ms. Evelyn Douglas J.D.
    Executive VP, Chief of Corporate Strategy & Business Development and General Counsel
  • Ms. Moyra Withycombe
    Interim Chief People Officer
  • Ms. Kjersti Grimsrud Biotechnology (Age 63)
    M.Sc., President & COO of Infusion Care
  • Mr. David Shepherd
    President & COO of Global Advanced Wound Care
  • Mr. Seth R. Segel (Age 55)
    President and COO of Continence Care & Home Services Group

CTEC Stock Analysis - Frequently Asked Questions

How have CTEC shares performed this year?

ConvaTec Group's stock was trading at GBX 244.20 at the beginning of 2024. Since then, CTEC stock has increased by 1.3% and is now trading at GBX 247.40.
View the best growth stocks for 2024 here

How were ConvaTec Group's earnings last quarter?

ConvaTec Group PLC (LON:CTEC) released its quarterly earnings data on Friday, February, 28th. The company reported $12.00 EPS for the quarter, missing analysts' consensus estimates of $12.70 by $0.70. ConvaTec Group had a net margin of 6.08% and a trailing twelve-month return on equity of 7.89%.

How do I buy shares of ConvaTec Group?

Shares of CTEC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What other stocks do shareholders of ConvaTec Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that ConvaTec Group investors own include EnQuest (ENQ), Centamin (CEY), Oxford Biomedica (OXB), Bristol-Myers Squibb (BMY), Andalas Energy and Power (ADL), AFR.L (AFR) and CBTX (CBTX).

This page (LON:CTEC) was last updated on 7/24/2024 by Staff

From Our Partners